| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Priority Reports |
1 Departments of 1Oncology and 2Biochemistry, McGill University, Montreal, Quebec, Canada and 3Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
* To whom correspondence should be addressed. E-mail: Michael.pollak{at}mcgill.ca.
 |
Abstract |
|---|
Recent population studies provide clues that the use of metformin may be associated with reduced incidence and improved prognosis of certain cancers. This drug is widely used in the treatment of type 2 diabetes, where it is often referred to as an "insulin sensitizer" because it not only lowers blood glucose but also reduces the hyperinsulinemia associated with insulin resistance. As insulin and insulin-like growth factors stimulate proliferation of many normal and transformed cell types, agents that facilitate signaling through these receptors would be expected to enhance proliferation. We show here that metformin acts as a growth inhibitor rather than an insulin sensitizer for epithelial cells. Breast cancer cells can be protected against metformin-induced growth inhibition by small interfering RNA against AMP kinase. This shows that AMP kinase pathway activation by metformin, recently shown to be necessary for metformin inhibition of gluconeogenesis in hepatocytes, is also involved in metformin-induced growth inhibition of epithelial cells. The growth inhibition was associated with decreased mammalian target of rapamycin and S6 kinase activation and a general decrease in mRNA translation. These results provide evidence for a mechanism that may contribute to the antineoplastic effects of metformin suggested by recent population studies and justify further work to explore potential roles for activators of AMP kinase in cancer prevention and treatment. (Cancer Res 2006; 66(21): 10269-73)
Key Words: prevention, LKB1, Peutz-Jeghers, proliferation, treatment
This article has been cited by other articles:
|
|
 |
|
  H. A. Hirsch, D. Iliopoulos, P. N. Tsichlis, and K. Struhl Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission Cancer Res., October 1, 2009; 69(19): 7507 - 7511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Grossmann, N. K. Mizuno, M. L. Dammen, T. Schuster, A. Ray, and M. P. Cleary Eleostearic Acid Inhibits Breast Cancer Proliferation by Means of an Oxidation-Dependent Mechanism Cancer Prevention Research, October 1, 2009; 2(10): 879 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kisfalvi, G. Eibl, J. Sinnett-Smith, and E. Rozengurt Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth Cancer Res., August 15, 2009; 69(16): 6539 - 6545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pollak Macronutrient Intake and Cancer: How Does Dietary Restriction Influence Tumor Growth and Why Should We Care? Cancer Prevention Research, August 1, 2009; 2(8): 698 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jiralerspong, S. L. Palla, S. H. Giordano, F. Meric-Bernstam, C. Liedtke, C. M. Barnett, L. Hsu, M.-C. Hung, G. N. Hortobagyi, and A. M. Gonzalez-Angulo Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer J. Clin. Oncol., July 10, 2009; 27(20): 3297 - 3302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Woo, E. S. Park, J.-S. Lee, Y.-H. Lee, T. Ishikawa, Y. J. Kim, and S. S. Thorgeirsson Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening Cancer Res., May 1, 2009; 69(9): 4059 - 4066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Fay, V. Steele, and J. A. Crowell Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase Cancer Prevention Research, April 1, 2009; 2(4): 301 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cazzaniga, B. Bonanni, A. Guerrieri-Gonzaga, and A. Decensi Is it Time to Test Metformin in Breast Cancer Clinical Trials? Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 701 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vazquez-Martin, C. Oliveras-Ferraros, S. del Barco, B. Martin-Castillo, and J. A. Menendez The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy Ann. Onc., March 1, 2009; 20(3): 592 - 595. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Menendez, A. Vazquez-Martin, F. J. Ortega, and J. M. Fernandez-Real Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer Clin. Chem., March 1, 2009; 55(3): 425 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Javle, A. Abernethy, N. L. Busaidy, and J. H. Lee Dilemmas in Upper Gastrointestinal Cancers: Focus on Symptom Improvement ASCO Educational Book, January 1, 2009; 2009(1): 228 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, P. Hao, S. Zheng, K. Tu, H. Fan, R. Zhu, G. Ding, C. Dong, C. Wang, X. Li, et al. Gene expression module-based chemical function similarity search Nucleic Acids Res., November 1, 2008; 36(20): e137 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Rosenbluth, D. J. Mays, M. F. Pino, L. J. Tang, and J. A. Pietenpol A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73 Mol. Cell. Biol., October 1, 2008; 28(19): 5951 - 5964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zakikhani, R. J.O. Dowling, N. Sonenberg, and M. N. Pollak The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase Cancer Prevention Research, October 1, 2008; 1(5): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Scarpello and H. C. Howlett Metformin therapy and clinical uses Diabetes and Vascular Disease Research, September 1, 2008; 5(3): 157 - 167. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Algire, M. Zakikhani, M.-J. Blouin, J. H. Shuai, and M. Pollak Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth Endocr. Relat. Cancer, September 1, 2008; 15(3): 833 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Turner, J.-Y. Li, A. Gosby, S. W.C. To, Z. Cheng, H. Miyoshi, M. M. Taketo, G. J. Cooney, E. W. Kraegen, D. E. James, et al. Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action Diabetes, May 1, 2008; 57(5): 1414 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goodwin Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions? J. Clin. Oncol., February 20, 2008; 26(6): 833 - 834. [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Kim, K.-G. Park, Y.-S. Lee, Y.-Y. Park, D.-K. Kim, B. Nedumaran, W. G. Jang, W.-J. Cho, J. Ha, I.-K. Lee, et al. Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP Diabetes, February 1, 2008; 57(2): 306 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uzbekova, Y. Arlot-Bonnemains, J. Dupont, R. Dalbies-Tran, P. Papillier, S. Pennetier, A. Thelie, C. Perreau, P. Mermillod, C. Prigent, et al. Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation Biol Reprod, February 1, 2008; 78(2): 218 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Jin, L. Feng, C. Behrens, B. N. Bekele, I. I. Wistuba, W.-K. Hong, and H.-Y. Lee Implication of AMP-Activated Protein Kinase and Akt-Regulated Survivin in Lung Cancer Chemopreventive Activities of Deguelin Cancer Res., December 15, 2007; 67(24): 11630 - 11639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Venkateswaran, A. Q. Haddad, N. E. Fleshner, R. Fan, L. M. Sugar, R. Nam, L. H. Klotz, and M. Pollak Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts J Natl Cancer Inst, December 5, 2007; 99(23): 1793 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J.O. Dowling, M. Zakikhani, I. G. Fantus, M. Pollak, and N. Sonenberg Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells Cancer Res., November 15, 2007; 67(22): 10804 - 10812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Jones, M. J. Haykowsky, J. J. Swartz, P. S. Douglas, and J. R. Mackey Early Breast Cancer Therapy and Cardiovascular Injury J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1435 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Forcet and M. Billaud Dialogue Between LKB1 and AMPK: A Hot Topic at the Cellular Pole Sci. Signal., September 18, 2007; 2007(404): pe51 - pe51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N Pollak Insulin, insulin-like growth factors, insulin resistance, and neoplasia Am. J. Clinical Nutrition, September 1, 2007; 86(3): 820S - 821S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Bowker and J. A. Johnson Prospective Study of Hyperglycemia and Cancer Risk: Response to Stattin et al. Diabetes Care, July 1, 2007; 30(7): e77 - e77. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
